<div class=”col-lg-9 content-page left-side”>
<section class=”section-a-single-resolutions resolutions-info top-content”>
<div class=”resolutions-contain”>
<div class=”top-content”>
<h4>Resolution Details</h4>
</div>
<div class=”bottom-content”>
<div class=”row-info”>
<strong>Company:</strong>
<p>Edwards Lifesciences</p>
</div>
<div class=”row-info”>
<strong>Year:</strong>
<p>2025 </p>
</div>
<div class=”row-info”>
<strong>Issue Area:</strong>
<p>Corporate Governance </p>
</div>
<div class=”row-info”>
<strong>Focus Area:</strong>
<p>CEO and Chair Separation </p>
</div>
<div class=”row-info”>
<strong>Status:</strong>
<p>Omitted</p>
</div>
<div class=”row-info”>
</a>
</div>
</div>
</div>
</section>
<section class=”section-b-single-resolutions content-blocks”>
<div class=”top-content editor-block”>
<div class=”content-block”>
<div class=”main-content”>
<h2>Resolution Text</h2>
<p>Shareholders request that the Board of Directors adopt an enduring policy, and amend the governing documents as necessary in order that 2 separate people hold the office of the Chairman and the office of the CEO.</p>
<p>Whenever possible, the Chairman of the Board shall be an Independent Director.</p>
<p>The Board has the discretion to select a Temporary Chairman of the Board who is not an Independent Director to serve while the Board is seeking an Independent Chairman of the Board on an expedited basis. </p>
<p>It is a best practice to adopt this policy soon. However this policy could be phased in when there is a contract renewal for our current CEO or for the next CEO transition.<br><br>The roles of Chairman and CEO are fundamentally different and should be held by 2 directors, a CEO and a Chairman who is completely independent of the CEO and our company.</p>
<p>A lead director is no substitute for an independent Board Chairman. </p>
<p>It is important to have an independent Board Chairman given the context of worse than stagnate Edwards Lifesciences long-term stock performance. The Edwards stock price was at $119 in 2022 and down to $70 in late 2024. Giving the 2 most important Edwards jobs to one person is not working at Edwards as illustrated in the worse than stagnate stock price.</p>
<p>The ascending complexities of a company with $40 Billion in market capitalization, like Edwards Lifesciences, increasingly demands that 2 persons fill the 2 most important jobs at Edwards Lifesciences on an enduring basis – Chairman and CEO.</p>
</div>
</div>
</div>
<div class=”middle-content editor-block”>
<div class=”content-block”>
<div class=”main-content”>
</div>
</div>
</div>
</section>
</div>
<aside class=”col-xl-3 right-side”>
<div class=”column-contain”>
<div class=”position-groups”>
<div class=”row bs-1col node node–type-resolution node–view-mode-resolution-filers-only”>
<div class=”col-sm-12 col-md-8 bs-region bs-region–main”>
<div class=”views-element-container form-group”>
<div class=”view view-eva view-filers view-id-filers view-display-id-entity_view_3 js-view-dom-id-ed557840502d739126a751f2aac6c0f7adfcfd95822074211d875cfd37b06ee7″>
<div class=”view-content”>
<h3>Lead Filer</h3>
<div class=”views-row”>
<div class=”views-field views-field-nothing”><span class=”field-content”> John Chevedden</span></div><div class=”views-field views-field-title views-field-field-shareholder”><span class=”field-content”>Chevedden Corporate Governance</span></div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</aside>